中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
20期
41-43
,共3页
慢性泪囊炎%泪道浚通术%球头硅胶管植入术%泪道浚通联合球头硅胶管植入术
慢性淚囊炎%淚道浚通術%毬頭硅膠管植入術%淚道浚通聯閤毬頭硅膠管植入術
만성루낭염%루도준통술%구두규효관식입술%루도준통연합구두규효관식입술
Chronic dacryocystitis%Probing of lacrimal passage%Ball head silicone tube implantation%Probing of lacrimal passage combined with the ball head silicone tube implantation
目的:比较泪道浚通术、球头硅胶管植入术、泪道浚通联合球头硅胶管植入术治疗慢性泪囊炎的效果。方法选择2012年2月~2013年9月在柳州市人民医院接受手术治疗的112例慢性泪囊炎患者(170眼)分为三组,58眼接受泪道浚通术(泪道浚通术组),57眼接受球头硅胶管植入术(球头硅胶管植入术组),55眼接受泪道浚通联合球头硅胶管植入术(联合术组)。所有患者随访期6~12个月,期间观察其临床症状的改善程度(包括泪道冲洗通畅度、泪道阻塞的症状和体征消失程度),以治愈、好转和无效作为疗效评价标准,计算有效率。结果泪道浚通组有效率为77.58%。球头硅胶管植入术组有效率80.70%。泪道浚通联合球头硅胶管植入术组有效率89.09%,联合术组与其他两组疗效比较,差异有统计学意义(P<0.05);泪道浚通术组和球头硅胶管植入术组有效率比较,差异无统计学意义(P>0.05)。结论三种手术方式中,泪道浚通联合球头硅胶管植入是治疗慢性泪囊炎最有效的方法,球头硅胶管植入术及泪道浚通术疗效次之,两者无显著差异。泪道浚通联合球头硅胶管植入术成本低廉,手术时间短,微创,值得推广运用。
目的:比較淚道浚通術、毬頭硅膠管植入術、淚道浚通聯閤毬頭硅膠管植入術治療慢性淚囊炎的效果。方法選擇2012年2月~2013年9月在柳州市人民醫院接受手術治療的112例慢性淚囊炎患者(170眼)分為三組,58眼接受淚道浚通術(淚道浚通術組),57眼接受毬頭硅膠管植入術(毬頭硅膠管植入術組),55眼接受淚道浚通聯閤毬頭硅膠管植入術(聯閤術組)。所有患者隨訪期6~12箇月,期間觀察其臨床癥狀的改善程度(包括淚道遲洗通暢度、淚道阻塞的癥狀和體徵消失程度),以治愈、好轉和無效作為療效評價標準,計算有效率。結果淚道浚通組有效率為77.58%。毬頭硅膠管植入術組有效率80.70%。淚道浚通聯閤毬頭硅膠管植入術組有效率89.09%,聯閤術組與其他兩組療效比較,差異有統計學意義(P<0.05);淚道浚通術組和毬頭硅膠管植入術組有效率比較,差異無統計學意義(P>0.05)。結論三種手術方式中,淚道浚通聯閤毬頭硅膠管植入是治療慢性淚囊炎最有效的方法,毬頭硅膠管植入術及淚道浚通術療效次之,兩者無顯著差異。淚道浚通聯閤毬頭硅膠管植入術成本低廉,手術時間短,微創,值得推廣運用。
목적:비교루도준통술、구두규효관식입술、루도준통연합구두규효관식입술치료만성루낭염적효과。방법선택2012년2월~2013년9월재류주시인민의원접수수술치료적112례만성루낭염환자(170안)분위삼조,58안접수루도준통술(루도준통술조),57안접수구두규효관식입술(구두규효관식입술조),55안접수루도준통연합구두규효관식입술(연합술조)。소유환자수방기6~12개월,기간관찰기림상증상적개선정도(포괄루도충세통창도、루도조새적증상화체정소실정도),이치유、호전화무효작위료효평개표준,계산유효솔。결과루도준통조유효솔위77.58%。구두규효관식입술조유효솔80.70%。루도준통연합구두규효관식입술조유효솔89.09%,연합술조여기타량조료효비교,차이유통계학의의(P<0.05);루도준통술조화구두규효관식입술조유효솔비교,차이무통계학의의(P>0.05)。결론삼충수술방식중,루도준통연합구두규효관식입시치료만성루낭염최유효적방법,구두규효관식입술급루도준통술료효차지,량자무현저차이。루도준통연합구두규효관식입술성본저렴,수술시간단,미창,치득추엄운용。
Objective To analyze the therapy effects of treating chronic dacryocystitis with probing of lacrimal passage, the ball head silicone tube implantation and probing of lacrimal passage combined with the ball head silicone tube im-plantation. Methods From February 2012 to September 2013, in the People's Hospital of Liuzhou City, 112 patiens (170 eyes) with chronic dacryocystitis were retrospectively analyzed and the data of patients were collected. 58 eyes were treated with probing of lacrimal passage (group 1), 57 eyes were treated with the ball head silicone tube implanta-tion (ball head silicone tube implantation group), and 55 eyes were treated with probing of lacrimal passage combined with the ball head silicone tube implantation (combined operation group). All patients were followed 6 to 12 months af-ter operation. Indexes like the patency of lacrimal passages, Lacrimal duct obstruction symptoms were observed and compared. As the standard to recurred, better and invalid, effective rate was calculated. Results The effective rate of probing of lacrimal passage group was 77.58%, that of ball head silicone tube implantation group was 80.70% and that of combined operation group was 89.09%. The effective rate of combined operation group was compared with those of the other two groups, the differences were statistically significant (P< 0.05), the effective rate of probing of lacrimal passage group and ball head silicone tube implantation group were compared, the difference was not statistically signifi-cant (P> 0.05). Conclusion Among the three ways of operation, probing of lacrimal passage in combination with the ball head silicone tube implantation is the best way to cure chronic dacryocystitis. The ball head silicone tube implan-tation and probing of lacrimal passage have good curative effect and there is no significant difference between the two ways. Probing of lacrimal passage in combination withhe ball head silicone tube implantation has the advantage of low cost, short operation time and minor injury, thus worth further clinical usage.